106 related articles for article (PubMed ID: 18608470)
1. Protection by Chinese herbs against Doxorubicin-induced focal and segmental glomerulosclerosis in rats.
Tong Y; Wang Q; Hou H
Drug Dev Ind Pharm; 2008 Jul; 34(7):663-7. PubMed ID: 18608470
[TBL] [Abstract][Full Text] [Related]
2. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
[TBL] [Abstract][Full Text] [Related]
3. The ovaries attenuate the aggravating effect of testosterone on glomerular injury in Adriamycin-induced nephropathy of female rats.
Sakemi T; Ohtsuka N; Tomiyoshi Y; Morito F
Kidney Blood Press Res; 1997; 20(1):44-50. PubMed ID: 9192910
[TBL] [Abstract][Full Text] [Related]
4. Pefloxacin in adriamycin induced nephrotic syndrome in the rat.
Korzets Z; Pomeranz A; Golan E; Bernheim J
Nephrol Dial Transplant; 1997 Feb; 12(2):286-8. PubMed ID: 9132646
[TBL] [Abstract][Full Text] [Related]
5. Salidroside Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis by Inhibiting the Hypoxia-Inducible Factor-1α Expression Through Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway.
Liu G; He L
Nephron; 2019; 142(3):243-252. PubMed ID: 30840958
[TBL] [Abstract][Full Text] [Related]
6. Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis.
Wapstra FH; van Goor H; de Jong PE; Navis G; de Zeeuw D
J Pharmacol Toxicol Methods; 1999; 41(2-3):69-73. PubMed ID: 10598677
[TBL] [Abstract][Full Text] [Related]
7. Sex difference in progression of adriamycin-induced nephropathy in rats.
Sakemi T; Ohtsuka N; Tomiyoshi Y; Morito F
Am J Nephrol; 1996; 16(6):540-7. PubMed ID: 8955769
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidinedione attenuate proteinuria and glomerulosclerosis in Adriamycin-induced nephropathy rats via slit diaphragm protection.
Liu HF; Guo LQ; Huang YY; Chen K; Tao JL; Li SM; Chen XW
Nephrology (Carlton); 2010 Feb; 15(1):75-83. PubMed ID: 20377774
[TBL] [Abstract][Full Text] [Related]
9. Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis.
Rangan GK; Coombes JD
Nephrol Dial Transplant; 2007 Aug; 22(8):2175-82. PubMed ID: 17550925
[TBL] [Abstract][Full Text] [Related]
10. Protection of Chinese herbs against adenine-induced chronic renal failure in rats.
Tong Y; Han B; Guo H; Liu Y
Afr J Tradit Complement Altern Med; 2010; 7(4):331-8. PubMed ID: 21731165
[TBL] [Abstract][Full Text] [Related]
11. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
12. Glomerulosclerosis 4 weeks after administration of adriamycin in a single dose.
Pedrycz A; Wieczorski M; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):214-9. PubMed ID: 16145983
[TBL] [Abstract][Full Text] [Related]
13. Huaiqihuang Granules () reduce proteinuria by enhancing nephrin expression and regulating necrosis factor κB signaling pathway in adriamycin-induced nephropathy.
Liu H; Sun W; Gu LB; Tu Y; Yu BY; Hu H
Chin J Integr Med; 2017 Apr; 23(4):279-287. PubMed ID: 26453563
[TBL] [Abstract][Full Text] [Related]
14. Adriamycin-induced glomerulosclerosis in the rat.
Bertani T; Rocchi G; Sacchi G; Mecca G; Remuzzi G
Am J Kidney Dis; 1986 Jan; 7(1):12-9. PubMed ID: 3510531
[TBL] [Abstract][Full Text] [Related]
15. Effects of enalapril on adriamycin-induced nephrosis.
Irwin KC; Brouhard BH; Satoh S; Stowe NT
Pediatr Nephrol; 1992 Sep; 6(5):448-50. PubMed ID: 1457325
[TBL] [Abstract][Full Text] [Related]
16. Effects of dietary protein, angiotensin I converting enzyme inhibition and mesangial overload on the progression of adriamycin-induced nephropathy.
Barretti P; Viero RM; Soares VA
Braz J Med Biol Res; 1995 Jan; 28(1):39-50. PubMed ID: 7581027
[TBL] [Abstract][Full Text] [Related]
17. Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic rats.
De Boer E; Navis G; Tiebosch AT; De Jong PE; De Zeeuw D
J Am Soc Nephrol; 1999 Nov; 10(11):2359-66. PubMed ID: 10541295
[TBL] [Abstract][Full Text] [Related]
18. C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis.
Rangan GK; Pippin JW; Couser WG
Kidney Int; 2004 Nov; 66(5):1838-48. PubMed ID: 15496154
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin attenuates the severity of murine adriamycin nephropathy.
Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
Am J Nephrol; 2009; 29(4):342-52. PubMed ID: 18948688
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-Gallate Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis via Suppression of Oxidant Stress and Apoptosis by Targeting Hypoxia-Inducible Factor-1α/ Angiopoietin-Like 4 Pathway.
Liu G; He L
Pharmacology; 2019; 103(5-6):303-314. PubMed ID: 30840953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
